LTAS
WST icon

Linden Thomas Advisory Services’s West Pharmaceutical WST Stock Holding History

Linden Thomas Advisory Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Sell
1,316
-10
-0.8% -$3.06K 0.04% 414
2026
Q1 		$332K Sell
1,326
-3,954
-75% -$984K 0.03% 425
2025
Q4 		$1.45M Buy
5,280
+104
+2% +$28.4K 0.15% 214
2025
Q3 		$1.36M Buy
5,176
+104
+2% +$25.3K 0.14% 234
2025
Q2 		$1.11M Buy
5,072
+140
+3% +$29.9K 0.12% 260
2025
Q1 		$1.1M Buy
4,932
+293
+6% +$80.8K 0.14% 259
2024
Q4 		$1.52M Buy
4,639
+351
+8% +$110K 0.19% 190
2024
Q3 		$1.29M Buy
4,288
+233
+6% +$71.4K 0.18% 229
2024
Q2 		$1.34M Buy
4,055
+1,322
+48% +$467K 0.21% 209
2024
Q1 		$1.08M Buy
2,733
+235
+9% +$86.9K 0.17% 245
2023
Q4 		$880K Buy
2,498
+261
+12% +$92.4K 0.16% 256
2023
Q3 		$839K Buy
2,237
+99
+5% +$38.3K 0.19% 231
2023
Q2 		$818K Buy
2,138
+171
+9% +$61.1K 0.18% 229
2023
Q1 		$682K Sell
1,967
-18
-0.9% -$5.26K 0.17% 239
2022
Q4 		$467K Buy
+1,985
New +$470K 0.13% 254

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Linden Thomas Advisory Services's WST Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its West Pharmaceutical (WST) stake by 0.75% in Q2 2026, selling an estimated $3.06K and leaving 1,316 shares worth $472K. The position accounts for 0.04% of the portfolio, ranked #414.

Linden Thomas Advisory Services first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.52M in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Linden Thomas Advisory Services held 1,316 shares of West Pharmaceutical worth $472K as of Q2 2026.
  • Linden Thomas Advisory Services sold 10 West Pharmaceutical shares in Q2 2026, an estimated $3.06K.
  • West Pharmaceutical made up 0.04% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #414 holding.
  • Linden Thomas Advisory Services first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's West Pharmaceutical position peaked at $1.52M in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.